Title : Biological Activity Evaluation of Novel 1,2,4-Triazine Derivatives Containing Thiazole\/Benzothiazole Rings - Yurttas_2017_Anticancer.Agents.Med.Chem_17_1846 |
Author(s) : Yurttas L , Ciftci GA , Temel HE , Saglik BN , Demir B , Levent S |
Ref : Anticancer Agents Med Chem , 17 :1846 , 2017 |
Abstract :
BACKGROUND: Triazine ring is a prominent structural motif found in some azanucleosides whose efficiency improved many times in the research area of antitumor agents. OBJECTIVE: In this study, we have designed and synthesized novel 2-[(5,6-diphenyl-1,2,4-triazin-3-yl)thio]-N-(6- substituted benzo/(thiazol)-2-yl)acetamide (2a-d, 3a-f) derivatives using 1,2,4-triazine core along with two important heterocyles, thiazole and benzothiazole rings. METHOD: The acquired ten final compounds were screened to investigate their antitumor activity against lung adenocarcinoma cell line, A549 and mouse fibroblast cell line, NIH/3T3. Five compounds with higher antiproliferative activity have been further studied to evaluate whether the cell death due to necrosis or apoptosis using flow cytometry. RESULTS AND CONCLUSION: Compound 3b bearing 6-methylbenzothiazole moiety has been established as the most active antitumor compound with a selective profile and higher apoptotic cell level. All final componds were also screened against acetylcholine/butyrylcholinesterase enzymes to state their anticholinesterase activity. |
PubMedSearch : Yurttas_2017_Anticancer.Agents.Med.Chem_17_1846 |
PubMedID: 28356019 |
Yurttas L, Ciftci GA, Temel HE, Saglik BN, Demir B, Levent S (2017)
Biological Activity Evaluation of Novel 1,2,4-Triazine Derivatives Containing Thiazole\/Benzothiazole Rings
Anticancer Agents Med Chem
17 :1846
Yurttas L, Ciftci GA, Temel HE, Saglik BN, Demir B, Levent S (2017)
Anticancer Agents Med Chem
17 :1846